On the one hand, a prospective, multinational, epidemiological study has shown that approximately 51.4% of Asian lung adenocarcinoma patients were with the epidermal growth factor receptor (EGFR) activating mutations [14]. The gene discussed is EGFR; the disease is lung adenocarcinoma.